key results

Key Results are by Workpackages. A link is provided to all published papers in the public domain.

 

UPLOADED PUBLICATIONS

A complete list of all uploaded publications on the website is provided here.

Key to Area Uploaded:

P - in the public domain. Links are provided to the publication websites.

S - accessible to the Steering Group.

W - accessible to Workpackage personnel only.

 

Type of Publication Title of Paper Work-package Area

Up-loaded

Workpackage 1: Understanding the Market

Working Paper Investing in New Medical Technologies: A Decision Framework 1.i W
Presentation Presentation at BSA Medical Sociology 06-09-07: Lost in Translation, A Sociological Examination of What Went Wrong with Tissue Engineering 1.i W
Notes to Presentation Notes to Presentation at BSA Medical Sociology 06-09-07: Lost in Translation, A Sociological Examination of What Went Wrong with Tissue Engineering 1.i  

W

Working paper From Bench to Bedside: The Translational Journey of Tissue Engineering 1.i W
Journal Paper Investing in new medical technologies: A decision framework 1.ii P
Journal Paper Cost-effectiveness analysis at the development phase of a potential health technology: examples based on tissue engineering of bladder and urethra 1.ii P
Working Paper Current clinical opportunities for bladder tissue engineering 1.ii S
Working Paper Current Clinical Opportunities for Regenerative Medicine in Bone 1.ii S
Journal Paper Cost-effectiveness analysis at the development phase of a potential health technology: examples based on tissue engineering of bladder and urethra 1.ii P
Workpackage 2: Policy Environment
Journal Paper Regulation of tissue-engineered products in the European Union: where are we heading? 2 P
Journal Paper What can be learnt from the Japanese regulatory approach to tissue engineered products? 2 P
Journal Paper Will regulation determine the science agenda? A look at hESCs 2 P
Working Paper On the Regulation of Tissue Engineered Products (TEPs) in the UK and EU 2 S
Working Paper Tissue Engineered Products: Challenging Aspects for the UK Regulatory Framework and Policy Environment 2 S
Briefing Note Briefing Note: On the Japanese Regulatory Approach to Tissue Engineered Products 2 S
Briefing Note Briefing Note: On the Current State of Regulation towards Regenerative Medicine in Singapore 2 S
Briefing Note Briefing Note: On the Regulation of Tissue Engineered products in the UK and US 2 S
Briefing Note Briefing Note: On the current state of the US Regulation towards Regenerative Medicine 2 S
Briefing Note Briefing Note: 4/11/05 On the current state of the European Union and UK Regulation towards Regenerative Medicine 2 S
Briefing Note Briefing Note: Tissue Engineering Products: Challenging aspects for the UK Regulatory Framework and Policy Environment 2 S
Briefing Note Regulatory Factsheet No. 1 2 S
Briefing Note Regulatory Factsheet No. 2 2 S
Briefing Note Regulatory Factsheet No. 3 2 S
Briefing Note Regulatory Factsheet No. 4 2 S
Briefing Note Regulatory Factsheet No. 5 2 S
Briefing Note Regulatory Factsheet No. 6 2 S
Presentation Regulation of Emerging Healthcare Technologies: The Need for a Renewed Regulatory Approach to Gain Public Confidence 2 W
Abstract to Presentation Regulation of Emerging Healthcare Technologies: The Need for a Renewed Regulatory Approach to Gain Public Confidence 2 W
Workpackage 3: Processing the Product
Journal Paper Tissue engineering and regenerative medicine: Manufacturing challenges 3 P
Workpackage 3.i: Scaffolds
Journal Paper 'Control of pore size and structure of tissue engineering scaffolds produced by supercritical fluid processing’, European Cells and Materials, in press 3.i P
Journal Paper Controlling Protein Release from Scaffolds Using Polymer Blends and Composites’, Eur J Pharm Biopharm 2007, in press 3.i P
Working Paper On the Process Capability of the Solid Freeform Fabrication: A Case Study of Scaffold Moulds for Tissue Engineering 3.i S
Working Paper Capability Analysis of Scaffolds made by the Supercritical Carbon dioxide Process 3.i S
Conference Poster Oxford 2007 Poster, "A Preliminary Study of the Process Capability of a Super Critical Fluid Scaffold Manufacturing Process" 3.i W
Conference Poster Toronto Termis 2007 Abstract, "Establishing the Process Capability of a Super Critical Fluid Scaffold Manufacturing Process 3.i W
Conference Presentation London Termis EU Presentation, "Analysis and Control of Process Conditions for Fabrication of Supercritical Fluid Foamed poly(D,L-lactic acid) Scaffolds 3.i W

Workpackage 3.ii: Cells

Journal Paper Applications of Precision Engineering Within the Medical Engineering Sector 3.ii P
Journal Paper Why Tissue Engineering Needs Process Engineering 3.ii P
Journal Paper Manufacture of a human mesenchymal stem cell population using an automated cell culture platform 3.ii P
Working Paper IP Space review for Tissue Engineering 3.ii S
Database IP Space database 3.ii S
Working Paper Automated hMSC culture using CompacT SelecT 3.ii S
Working Paper Applications of Precision Engineering Within the Medical Engineering Sector, Proceedings of the 7th euspen Interntational Conference, Bremen, - May 2007, 4-21 3.ii S
Working Paper Culture of Articular Chondrocytes in vitro 3.ii S
Working Paper Challenges of Culturing Functioning Cells in vitro for Regenerative Medicine and Stem Cell Therapy from a Process Perspective 3.ii S
Working Paper Review of islet cell expansion in vitro 3.ii S
Working Paper Cell Culture Media with Serum Free or Chemically Defined Formulations 3.ii S
Working Paper Demonstrating the Automated Culture of Murine Embryonic Stem Cell Lines 3.ii S
Working Paper Process Characterisation of the Automated (CompacT SelecT) Cell Culture of Osteoblasts 3.ii S
Working Paper Pre-production Measurement System Analysis (MSA) and Automated Cell Counting Systems 3.ii S
Working Paper Process Characterisation of the Automated (CompacT SelecT) Cell Culture of Osteoblasts: Cause and Effect Matrix 3.ii S
Working Paper Process Characterisation of the Manual Cell Culture of Osteoblasts: Process Map 3.ii S
Working Paper Process Characterisation of the Manual Cell Culture of Osteoblasts: Cost Pareto 3.ii S
Conference Presentation London Termis EU, "Measurement System Capability: A Comparison of Manual and Automated Cell Counting Systems" 3.ii W
Conference Poster Toronto Termis 2007, "Automated Culture and Quality Engineering of Human Mesenchymal Stem Cells" 3.ii W
Conference Presentation SelecT Users Group Meeting, Basel, 2007, "Innovative Manufacturing Grand Challenge: Regenerative Medicine - A New Industry" 3.ii W
Conference Presentation ELRIG Conference, Hinxton Hall, 2007, "Cell Culture Automation Within remedi" 3.ii W
Conference Presentation MDT Conference 2007, Birmingham, "Assessing the Future of Manufacturing in Europe" 3.ii W
Conference Presentation Bioreactor Design & Stem Cell Processing Workshop, Buxton, 2006, "Innovative Manufacturing Grand Challenge: Regenerative Medicine - A New Industry" 3.ii W
Workpackage 3.iii: Tissues
Conference Paper The Role of Mechanical Stimulation in Engineering of Extracellular Matrix (ECM) 3.iii P
Conference Paper Requirements for the manufacturing of scaffold biomaterials with features at multiples scales 3.iii P
Conference Paper Current developments in tissue engineering of nucleus pulposus for the treatment of intervertebral disc degeneration 3.iii P
Working Paper Modelling of the Growth of Cells and Extracellular Matrix Synthesis in Scaffolds for in vitro Tissue Engineering 3.iii S
Working Paper Injectable Scaffolds of Tissue Engineering and Regenerative Medicine 3.iii S
Working Paper Intervertebral Disc: Opportunities for Cell and Tissue Based Therapies 3.iii S
Working Paper Tissue Engineering of the Meniscus 3.iii S
Working Paper Millennium Biologix: Cell and Tissue Based Therapies 3.iii S
Working Paper Literature Review of Trypsinisation 3.iii S
Conference Presentation New York, USA, IEEE EMBC 2006, "The Role of Mechanical Stimulation in Engineering of Extracellular Matrix (ECM)" 3.iii W
Conference Presentation Rotterdam, The Netherlands, Termis EU, 2006, "Requirements of Specialised Bioreactor for Engineering and Characterisation of Extracellular Matrix" 3.iii W
Conference Presentation Lyon, France, IEEE, 2007, "Current Developments in Tissue Engineering of Nucleus Pulposus for the Treatment of Intervertebral Disc Degeneration" 3.iii W
Conference Presentation ASME, "Requirements for the Manufacturing of Scaffolds with Features at Multiple Scales" 3.iii W
Conference Poster Toronto Termis 2007, "Identification of Optimum Cell Seeding Strategy for Three Dimensional Scaffolds for in vitro Tissue Engineering 3.iii W
Conference Abstract Toronto Termis, 2007 Abstract, "Modelling of the Growth of the Cells and Extracellular Matrix Synthesis in Scaffolds for in vitro Tissue Engineering" 3.iii W
Conference Presentation Toronto Termis, 2007 Presentation, "Modelling of the Growth of the Cells and Extracellular Matrix Synthesis in Scaffolds for in vitro Tissue Engineering" 3.iii W
Workpackage 4: Characterisation and Control
Journal Paper Meeting the needs of monitoring in tissue engineering 4.i P
Working Paper Review of Critical Metrics for Cell and Tissue Growth Characterisation and Identification of Candidate Sensors for Off and In Line Measurement 4.i S
Working Paper Meeting the Needs of Monitoring in Tissue Engineering 4.i S
Working Paper Review of the use of Raman Spectroscopy for Non-Invasive Monitoring in Regenerative Medicine and Tissue Engineering 4.ii S
Working Paper Review of the use of Raman spectroscopy for detection of biological processes in vitro 4.ii S
Working Paper Image Based Characterisation of Foamed Polymeric Tissue Scaffolds 4.i S
Audit Presentation WP 4 Audit for 19 June 2007 - Nottingham Presentation 4.i W
Audit Presentation WP 4 Audit for 19 June 2007 - Ulster Presentation 4.ii W